Striatal pleiotrophin overexpression provides functional and morphological neuroprotection in the 6-hydroxydopamine model.
about
Morphological and behavioral impact of AAV2/5-mediated overexpression of human wildtype alpha-synuclein in the rat nigrostriatal systemBehavioral and neuroanatomical abnormalities in pleiotrophin knockout mice.Recombinant adenoassociated virus 2/5-mediated gene transfer is reduced in the aged rat midbrain.The longitudinal transcriptomic response of the substantia nigra to intrastriatal 6-hydroxydopamine reveals significant upregulation of regeneration-associated genes.Nogo-A Neutralization Improves Graft Function in a Rat Model of Parkinson's Disease.Impact of age and vector construct on striatal and nigral transgene expression.Targeting midkine and pleiotrophin signalling pathways in addiction and neurodegenerative disorders: recent progress and perspectives.ADSC therapy in neurodegenerative disorders.Neuroprotective potential of pleiotrophin overexpression in the striatonigral pathway compared with overexpression in both the striatonigral and nigrostriatal pathways.High-Frequency Stimulation of the Rat Entopeduncular Nucleus Does Not Provide Functional or Morphological Neuroprotection from 6-Hydroxydopamine.Peripheral administration of the selective inhibitor of soluble tumor necrosis factor (TNF) XPro®1595 attenuates nigral cell loss and glial activation in 6-OHDA hemiparkinsonian rats.Subthalamic Nucleus Deep Brain Stimulation Does Not Modify the Functional Deficits or Axonopathy Induced by Nigrostriatal α-Synuclein Overexpression.Development of inhibitors of receptor protein tyrosine phosphatase β/ζ (PTPRZ1) as candidates for CNS disorders.
P2860
Q30446265-3756E670-877F-4C95-A9B3-E4C856EDB9EEQ33856705-72B75B04-7CB3-4EF1-A78A-1CE3495CBEC8Q35044451-A8D7DFC9-DE42-440B-A25A-9DBD1E448DFCQ35628981-C4600CE3-2AFF-484F-AC03-5B27F1F8B0C9Q36766341-85406222-7717-4CA4-8287-C4D2DA096D70Q37481547-B62CA6C2-EF4A-4A2D-AED4-9092D2740CE0Q38124378-9358EE56-4FBF-4143-858A-916E8F34FC73Q38210872-CB0F2901-F5B5-4678-AE0F-AD0B93BEE407Q38997247-A1C671CB-D467-4378-8513-88298B03B4BEQ41953160-B65291A1-B7B6-478A-B2A5-59F24CC24A52Q42001519-2F75E5F4-C2D7-4CEB-9F4C-C4415112A384Q47111833-E1F9CE43-3174-4F14-80F5-F8D1789E8DCDQ47257582-315C88FE-61BD-4DD3-AABA-10F1501F9613
P2860
Striatal pleiotrophin overexpression provides functional and morphological neuroprotection in the 6-hydroxydopamine model.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Striatal pleiotrophin overexpr ...... n the 6-hydroxydopamine model.
@ast
Striatal pleiotrophin overexpr ...... n the 6-hydroxydopamine model.
@en
type
label
Striatal pleiotrophin overexpr ...... n the 6-hydroxydopamine model.
@ast
Striatal pleiotrophin overexpr ...... n the 6-hydroxydopamine model.
@en
prefLabel
Striatal pleiotrophin overexpr ...... n the 6-hydroxydopamine model.
@ast
Striatal pleiotrophin overexpr ...... n the 6-hydroxydopamine model.
@en
P2093
P2860
P356
P1433
P1476
Striatal pleiotrophin overexpr ...... n the 6-hydroxydopamine model.
@en
P2093
Allyson Cole-Strauss
Anne L Spieles-Engemann
Brian F Daley
Brian T Terpstra
Caryl E Sortwell
Fredric P Manfredsson
Jack W Lipton
Lalitha Madhavan
Ronald J Mandel
Sara E Gombash
P2860
P304
P356
10.1038/MT.2011.216
P577
2011-10-18T00:00:00Z